'''Covaxin''' (codenamed as '''BBV152''') is an [[Inactivated vaccine|inactivated virus]]-based [[COVID-19 vaccine]] created by [[Bharat Biotech]]. 
 
 As of October 2021, 110.6 million people in India have received Covaxin. < ref > {{Cite web|date=23 October 2021|title=Cowin statistics|url=https://dashboard.cowin.gov.in/|website=Cowin|publisher=Ministry of health and family welfare India}} < /ref >  On 3 November 2021, the [[World Health Organization]] (WHO) approved the vaccine for emergency use. < ref > {{cite news |title=India's first homegrown COVID-19 shot wins WHO emergency use listing |url=https://www.reuters.com/world/india/whos-advisory-group-recommends-emergency-listing-indias-first-homegrown-covid-19-2021-11-03/ |work=Reuters |date=3 November 2021 |language=en}} < /ref > < ref name= " WHO PR 20211103 " > {{cite press release | title=WHO issues emergency use listing for eighth COVID-19 vaccine | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/03-11-2021-who-issues-emergency-use-listing-for-eighth-covid-19-vaccine | access-date=3 November 2021}} < /ref > 
 
 ==References== 
 {{reflist}} 
 
 [[Category:COVID-19 pandemic]] 
 
 {{medicine-stub}}